Jian Hu
- Cancer Research top 2%
- MicroRNA in disease regulation 8
- Aging top 2%
- Genetics top 2%
- Glioma Diagnosis and Treatment 12
- Molecular Biology top 2%
- Fibroblast Growth Factor Research 13
- Epigenetics and DNA Methylation 9
- Kruppel-like factors research 8
- RNA Research and Splicing 8
- Neurology top 5%
-
- Pulmonary Hypertension Research and Treatments 9
-
- Immune cells in cancer 7
- Co-authors
- Ronald A. DePinhoBoyi GanLynda ChinErgün SahinJianhua ZhangEliot Fletcher-SananikoneTakashi ShinguXingzhi Song
- Cited by
- Cancer ResearchAgingGenetics
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Jian Hu
100 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 962
- Aging 103
- Genetics 497
- Molecular Biology 2.6k
- Neurology 214
Countries citing papers authored by Jian Hu
This map shows the geographic impact of Jian Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Hu more than expected).
Fields of papers citing papers by Jian Hu
This network shows the impact of papers produced by Jian Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Hu. The network helps show where Jian Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jian Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2022 | 13 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 30 | |
| 6 | 2022 | 29 | |
| 7 | 2022 | 16 | |
| 8 | 2021 | 30 | |
| 9 | 2021 | 11 | |
| 10 | PM2.5 Induces the Expression of Inflammatory Cytokines via the Wnt5a/Ror2 Pathway in Human Bronchial Epithelial Cells | 2020 | 1 |
| 11 | Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response | 2020 | 1 |
| 12 | 2020 | 51 | |
| 13 | 2018 | 91 | |
| 14 | 2017 | 59 | |
| 15 | 2017 | 22 | |
| 16 | miR-26a suppresses gastric cancer cell invasion by targeting MMP16 | 2016 | 1 |
| 17 | 2015 | 3 | |
| 18 | 2011 | 7 | |
| 19 | 2010 | 116 | |
| 20 | 2010 | 203 |
About Jian Hu
Jian Hu is a scholar working on Genetics, Neurology and Developmental Neuroscience, having authored 104 papers that have together received 4.3k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (13 papers), Glioma Diagnosis and Treatment (12 papers), Epigenetics and DNA Methylation (9 papers), Pulmonary Hypertension Research and Treatments (9 papers), MicroRNA in disease regulation (8 papers), Kruppel-like factors research (8 papers), RNA Research and Splicing (8 papers) and Immune cells in cancer (7 papers). The work is most often cited by research in Cancer Research (962 citations), Aging (103 citations) and Genetics (497 citations). Jian Hu has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Ronald A. DePinho, Boyi Gan, Lynda Chin, Ergün Sahin, Jianhua Zhang, Eliot Fletcher-Sananikone, Takashi Shingu, Xingzhi Song, Li Lin and Fei Gao. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.